Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Canada Approves Second Generic Version Of Ozempic

The ⁠Canadian health regulator ⁠said on ⁠Friday that ‌it had approved Canada-based Apotex's generic ‌version of semaglutide, making ‌it ‌the second copycat ⁠version of...

Constipation Linked to Greater Weight Loss on Semaglutide

Patients on semaglutide who experienced constipation had greater weight loss than those without constipation, and genes could be at play.

GLP-1 Semaglutide Promising for Alcohol Use Disorder

Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol use disorder.

Diabetes Before Pregnancy May Affect Kids’ Brain Development

Children of mothers with pregestational diabetes may have an increased risk of developing subsequent neuropsychiatric disorders.

GLP-1 Drugs May Modestly Raise Optic Neuropathy Risk in T2D

GLP-1 therapy is linked to a modestly increased risk for nonarteritic anterior ischemic optic neuropathy compared with SGLT2 inhibitors in veterans with type 2 diabetes.

Capecitabine Extends PFS in Oesophagogastric Cancer

Maintenance therapy with capecitabine prolongs progression-free survival in patients with advanced oesophagogastric adenocarcinoma after first-line chemotherapy.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Latest News

The ⁠Canadian health regulator ⁠said on ⁠Friday that ‌it had approved Canada-based Apotex's generic ‌version of semaglutide, making ‌it ‌the second copycat ⁠version of...

Patients on semaglutide who experienced constipation had greater weight loss than those without constipation, and genes could be at play.

Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol use disorder.

Children of mothers with pregestational diabetes may have an increased risk of developing subsequent neuropsychiatric disorders.

GLP-1 therapy is linked to a modestly increased risk for nonarteritic anterior ischemic optic neuropathy compared with SGLT2 inhibitors in veterans with type 2 diabetes.

Maintenance therapy with capecitabine prolongs progression-free survival in patients with advanced oesophagogastric adenocarcinoma after first-line chemotherapy.

News All Time

FDA Proposes End to Mass GLP-1 Compounding

The agency appears to leave a loophole for patient-specific formulations.

Food Insecurity and Poverty May Raise MASLD Risk in US

People who do not have enough food to eat or who live below the poverty level are more likely to develop MASLD, and this risk is higher in non-Hispanic White individuals.

‘Cyborg’ Islet Cells and Potential New Diabetes Therapies

Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of previously unseen data on islet cell function.

Canada Approves First Generic Version Of Ozempic Amid Rising GLP-1 Competition

Health Canada has approved the first generic version of Danish drugmaker Novo Nordisk's blockbuster diabetes drug Ozempic made ⁠by Indian drugmaker Dr Reddy's Laboratories,...

Autusm Advisory Board Focuses on 'profound Autism,' Improved Medical Care

A U.S. advisory committee appointed by Health Secretary Robert F. Kennedy Jr. recommended on Tuesday that the government adopt the term "profound autism” for those with the...

Migraine Med Shows Weight-Loss Benefit

New data show early and sustained weight loss with atogepant, raising the possibility of metabolic benefits beyond migraine prevention.

HIV Patients in Senegal Skip Treatment Amid LGBTQ Arrests

Fewer patients are visiting some HIV treatment centres in Senegal amid a wave of arrests targeting LGBTQ people, threatening the country's fight against the virus.

Germany to Impose Levy on Sugary Drinks From 2028

Germany plans to impose a levy on sugary drinks under a healthcare reform package that aims to rein in rising rates of ⁠obesity and ease pressure on the health system.

Sleep Disorders Very Common in Patients With Osteoarthritis

While pain is recognized as a likely contributor to poor sleep, the relationship may be bidirectional, with sleep problems also contributing to osteoarthritis symptoms.

Brolucizumab Beats Laser Treatment in Diabetic Retinopathy

Intravitreal brolucizumab is superior to panretinal laser photocoagulation in preserving visual acuity for patients with proliferative diabetic retinopathy, clinical trial data show.

Bariatric Surgery Adapts to the GLP-1 Era

As GLP-1 use increases and bariatric surgery rates decline, practices are pivoting to comprehensive obesity care that integrates medical and surgical approaches.

Boehringer-Zealand Drug Leads to 16.6% Weight Loss in Late-stage Trial

Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight loss of up to 16.6% in ⁠a late-stage trial, as the unlisted German drugmaker seeks...

Mobile App for Hand Osteoarthritis Improves Pain, Function

Though currently available only in Norwegian, the researchers are expanding the app to more languages, including English.

Low Obesity-Related QOL Motivates Kids Weight Management

Families may be more motivated to participate in a pediatric weight management program when children and adolescents experience lower obesity-related quality of life.

OA, Knee Replacement Risk Highest With Sarcopenic Obesity

The findings suggest that resistance training is an important adjunct to other exercise for patients with knee osteoarthritis.

Women With Acromegaly Face Greater Disease Burden Than Men

Women with acromegaly experience a significantly higher disease burden and poorer physical and mental quality of life than men.

Recommended News For You

Prior authorizations draining time, energy from many cancer patients

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

Regular physical activity before cancer diagnosis may lower progression and death risks

combating racial discrimination in next-generation breast cancer screening.

A new theranostic drug targets different cancer types.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Recommended Articles For You

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights 

Unmasking the Subtle Symptoms of Colon Cancer 

Survival Rates in Cancer: Focus on Acute Myeloid Leukemia and Other Malignancies 

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035

2.

When Should Immunocompromised Individuals Receive a COVID Booster?

3.

Novel biomarker has potential for predicting and treating skin cancer metastasis

4.

Taking Charge of Your Cancer Journey.

5.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

1.

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection

2.

The Statistical Imperative: Navigating Trends, Precision, and Innovation in Gynecologic Oncology 2025

3.

Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy

4.

Cowden Syndrome and Cancer: Understanding the Risk Factors 

5.

Cemiplimab: A Revolutionary Drug For Treating Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

2.

Efficient Management of First line ALK-rearranged NSCLC

3.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

5.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot